Time-sensitive assessment of luteal phase progesterone after HCG ovulation triggering: another brick off the wall?


Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
11 2023
Historique:
received: 14 06 2023
revised: 28 07 2023
accepted: 28 07 2023
medline: 13 11 2023
pubmed: 17 9 2023
entrez: 16 9 2023
Statut: ppublish

Résumé

In recent years, there has been growing interest in understanding the dynamics of progesterone levels during the luteal phase after HCG-triggered ovulation. Recent studies have provided data showing a deviation from the natural ovulatory cycle, with peak progesterone concentrations occurring earlier and declining steadily thereafter, demonstrating that a fall in progesterone concentration early in the luteal phase was associated with lower rates of ongoing pregnancy. These findings highlight the importance of changes in progesterone concentration, rather than absolute concentrations, in determining optimal endometrial conditions. The disadvantages of HCG triggering, including the lack of a natural FSH surge and asynchronization between embryo age and endometrium receptivity, can be addressed by using gonadotrophin-releasing hormone agonist (GnRHa) triggering. GnRHa triggering induces both LH and FSH surges, ensures appropriate progesterone concentrations and offers flexibility in manipulating the luteal phase. Transitioning to GnRHa triggering could improve infertility treatment.

Identifiants

pubmed: 37716193
pii: S1472-6483(23)00424-8
doi: 10.1016/j.rbmo.2023.103324
pii:
doi:

Substances chimiques

Progesterone 4G7DS2Q64Y
Follicle Stimulating Hormone 9002-68-0
Gonadotropin-Releasing Hormone 33515-09-2
Chorionic Gonadotropin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103324

Informations de copyright

Copyright © 2023 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Auteurs

Juan Castillo (J)

Department of Reproductive Medicine, Instituto Bernabeu, Alicante, Spain.

Shahar Kol (S)

IVF unit, Elisha Hospital, Haifa, Israel. Electronic address: kol@elishahospital.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH